QuidelOrtho (QDEL) EBITDA (2021 - 2025)
QuidelOrtho (QDEL) has disclosed EBITDA for 5 consecutive years, with -$126.4 million as the latest value for Q4 2025.
- Quarterly EBITDA rose 40.12% to -$126.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 billion through Dec 2025, up 47.72% year-over-year, with the annual reading at -$1.1 billion for FY2025, 46.02% up from the prior year.
- EBITDA hit -$126.4 million in Q4 2025 for QuidelOrtho, up from -$768.9 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $620.7 million in Q2 2022 to a low of -$1.8 billion in Q1 2024.
- Historically, EBITDA has averaged -$97.7 million across 5 years, with a median of $12.2 million in 2021.
- Biggest five-year swings in EBITDA: skyrocketed 242.06% in 2022 and later crashed 64175.0% in 2025.
- Year by year, EBITDA stood at $281.8 million in 2021, then crashed by 79.84% to $56.8 million in 2022, then plummeted by 46.83% to $30.2 million in 2023, then plummeted by 799.01% to -$211.1 million in 2024, then surged by 40.12% to -$126.4 million in 2025.
- Business Quant data shows EBITDA for QDEL at -$126.4 million in Q4 2025, -$768.9 million in Q3 2025, and -$211.1 million in Q4 2024.